LIVER FAILURE
Clinical trials for LIVER FAILURE explained in plain language.
Never miss a new study
Get alerted when new LIVER FAILURE trials appear
Sign up with your email to follow new studies for LIVER FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Artificial liver device shows promise in early human trial
Disease control Recruiting nowThis study tests a new bioartificial liver device (CiPS-BAL) in 12 people with liver failure or small-for-size syndrome. The main goal is to see if the device is safe and tolerable. Researchers will also check how it affects liver function and other health measures. The device us…
Matched conditions: LIVER FAILURE
Phase: PHASE1, PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated May 26, 2026 10:39 UTC
-
New study finds right dose of cancer drug for patients with liver issues
Disease control Recruiting nowThis study is for people with advanced solid tumors who also have moderate liver problems. Researchers want to find a safe starting dose of the drug sacituzumab govitecan. About 30 participants will be monitored for side effects and how the drug moves through the body.
Matched conditions: LIVER FAILURE
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Diabetes drug shows promise for correcting dangerous low sodium levels
Disease control Recruiting nowThis study tests whether empagliflozin (Jardiance), a diabetes drug, can safely raise low sodium levels in patients with certain conditions like liver or kidney failure. About 172 adults with chronic low sodium will receive either the drug or a placebo for up to 30 days. The goal…
Matched conditions: LIVER FAILURE
Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Could a diabetes pill drain dangerous fluid from liver patients?
Disease control Recruiting nowThis study tests whether empagliflozin, a drug used for diabetes, can help people with cirrhosis (liver scarring) and ascites (belly fluid buildup) get rid of excess salt and water. About 20 adults on stable diuretics will receive either the drug or a placebo for 14 days. The goa…
Matched conditions: LIVER FAILURE
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Gut bacteria cocktail could be new weapon against liver failure
Disease control Recruiting nowThis early-stage trial tests whether giving a mix of healthy gut bacteria to people hospitalized with liver disease is safe and tolerable. The bacteria come from healthy donors and are designed to restore missing gut microbes. 24 adults with liver failure or cirrhosis will receiv…
Matched conditions: LIVER FAILURE
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Can stem cells in a blood filter help failing livers?
Disease control Recruiting nowThis early study tests a new approach for adults with liver failure: using stem cells in a blood purification machine. The stem cells work outside the body to filter the blood. Researchers want to see if this treatment is safe and can improve survival at 28 days. Ten participants…
Matched conditions: LIVER FAILURE
Phase: PHASE1 • Sponsor: Kebo Zhong • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New model aims to predict liver failure risk after cancer surgery
Knowledge-focused Recruiting nowThis study looks at whether the amount of healthy liver tissue removed during surgery can help predict a serious complication called liver failure. Researchers will create a model using this volume measurement and test it on 1,600 liver cancer patients. The goal is to give surgeo…
Matched conditions: LIVER FAILURE
Sponsor: National Natural Science Foundation of China • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC